Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors - Global Market Insights and Sales Trends 2024

Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors - Market

SGLT2 is a member of the sodium-glucose cotransporter family which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransporter involved in glucose reabsorption in the kidney.The growing global type-2 diabetes population promotes the growth of SGLT2 drugs.

The global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors in various end use industries. The expanding demands from the Hospital, Medical Research Institute and Other,, are propelling Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market. Invokana (Canagliflozin), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Jardiance (Empagliflozin) segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market, driven by demand from China, the second largest economy with some signs of stabilising, the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors covered in this report include Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb and Kotobuki Pharmaceutical, etc.

The global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Eli Lilly

Janssen Pharmaceuticals

Astellas

Boehringer Ingelheim

AstraZeneca

Bristol Myers Squibb

Kotobuki Pharmaceutical

Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market, by region:

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market, Segment by Type:

Invokana (Canagliflozin)

Jardiance (Empagliflozin)

Farxiga/Forxiga (Dapagliflozin)

Suglat (Ipragliflozin)

Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market, by Application

Hospital

Medical Research Institute

Other

Scope of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors - Market Report

Core Chapters

1.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Overview

1.2 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment by Type

1.2.1 Invokana (Canagliflozin)

1.2.2 Jardiance (Empagliflozin)

1.2.3 Farxiga/Forxiga (Dapagliflozin)

1.2.4 Suglat (Ipragliflozin)

1.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type

1.3.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Overview by Type (2018-2029)

1.3.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size Review by Type (2018-2023)

1.3.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2018-2023)

1.4.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Type (2018-2023)

2.1 Global Top Players by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (2018-2023)

2.2 Global Top Players by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2018-2023)

2.3 Global Top Players by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (2018-2023)

2.4 Global Top Manufacturers Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base Distribution, Sales Area, Product Type

2.5 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Competitive Situation and Trends

2.5.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors as of 2022)

2.7 Date of Key Manufacturers Enter into Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market

2.8 Key Manufacturers Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

2.9 Mergers & Acquisitions, Expansion

3.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size by Region

3.2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Region (2018-2023)

3.2.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Region (2018-2023)

3.2.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Region

3.3.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Region (2024-2029)

3.3.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Region (2024-2029)

3.3.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)

4.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment by Application

4.1.1 Hospital

4.1.2 Medical Research Institute

4.1.3 Other

4.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application

4.2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Overview by Application (2018-2029)

4.2.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size Review by Application (2018-2023)

4.2.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2018-2023)

4.3.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Breakdown by Application (2018-2023)

5.1 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size by Country

5.1.1 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2018-2023)

5.1.3 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2018-2023)

5.2 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Country

5.2.1 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2024-2029)

5.2.2 North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2024-2029)

6.1 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size by Country

6.1.1 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2018-2023)

6.1.3 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2018-2023)

6.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Country

6.2.1 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2024-2029)

6.2.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2024-2029)

7.1 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size by Region

7.1.1 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Region

7.2.1 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Region (2024-2029)

8.1 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size by Country

8.1.1 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2018-2023)

8.1.3 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2018-2023)

8.2 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Country

8.2.1 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2024-2029)

8.2.2 Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2024-2029)

9.1 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Size by Country

9.1.1 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Market Size by Country

9.2.1 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value by Country (2024-2029)

10.1 Eli Lilly

10.1.1 Eli Lilly Company Information

10.1.2 Eli Lilly Introduction and Business Overview

10.1.3 Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

10.1.5 Eli Lilly Recent Development

10.2 Janssen Pharmaceuticals

10.2.1 Janssen Pharmaceuticals Company Information

10.2.2 Janssen Pharmaceuticals Introduction and Business Overview

10.2.3 Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

10.2.5 Janssen Pharmaceuticals Recent Development

10.3 Astellas

10.3.1 Astellas Company Information

10.3.2 Astellas Introduction and Business Overview

10.3.3 Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

10.3.5 Astellas Recent Development

10.4 Boehringer Ingelheim

10.4.1 Boehringer Ingelheim Company Information

10.4.2 Boehringer Ingelheim Introduction and Business Overview

10.4.3 Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

10.4.5 Boehringer Ingelheim Recent Development

10.5 AstraZeneca

10.5.1 AstraZeneca Company Information

10.5.2 AstraZeneca Introduction and Business Overview

10.5.3 AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2018-2023)

10.5.4 AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

10.5.5 AstraZeneca Recent Development

10.6 Bristol Myers Squibb

10.6.1 Bristol Myers Squibb Company Information

10.6.2 Bristol Myers Squibb Introduction and Business Overview

10.6.3 Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

10.6.5 Bristol Myers Squibb Recent Development

10.7 Kotobuki Pharmaceutical

10.7.1 Kotobuki Pharmaceutical Company Information

10.7.2 Kotobuki Pharmaceutical Introduction and Business Overview

10.7.3 Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

10.7.5 Kotobuki Pharmaceutical Recent Development

11.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Industrial Chain Analysis

11.4 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Dynamics

11.4.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Trends

11.4.2 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers

11.4.3 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Challenges

11.4.4 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints

12.1 Sales Channel

12.2 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors

12.3 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream Customers

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

    Table 1. Major Company of Invokana (Canagliflozin)

    Table 2. Major Company of Jardiance (Empagliflozin)

    Table 3. Major Company of Farxiga/Forxiga (Dapagliflozin)

    Table 4. Major Company of Suglat (Ipragliflozin)

    Table 5. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

    Table 6. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (K Units)

    Table 7. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Type (2018-2023)

    Table 8. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (US& Million)

    Table 9. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share in Value by Type (2018-2023)

    Table 10. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2018-2023) & (USD/Unit)

    Table 11. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2024-2029) & (K Units)

    Table 12. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Type (2024-2029)

    Table 13. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2024-2029) & (US$ Million)

    Table 14. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Type (2024-2029)

    Table 15. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2024-2029) & (USD/Unit)

    Table 16. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (K Units)

    Table 17. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (US$ Million)

    Table 18. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units) by Type (2018-2023)

    Table 19. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (US$ Million)

    Table 20. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units) by Type (2018-2023)

    Table 21. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (US$ Million)

    Table 22. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units) by Type (2018-2023)

    Table 23. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (US$ Million)

    Table 24. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units) by Type (2018-2023)

    Table 25. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2023) & (US$ Million)

    Table 26. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2018-2023) & (K Units)

    Table 27. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Company (2018-2023)

    Table 28. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2018-2023) & (US$ Million)

    Table 29. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Company (2018-2023)

    Table 30. Global Market Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Company (2018-2023) & (USD/Unit)

    Table 31. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area

    Table 32. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors as of 2022)

    Table 34. Date of Key Manufacturers Enter into Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market

    Table 35. Key Manufacturers Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type

    Table 36. Mergers & Acquisitions, Expansion Plans

    Table 37. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2018-2023) & (K Units)

    Table 39. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Region (2018-2023)

    Table 40. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2018-2023) & (US$ Million)

    Table 41. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Region (2018-2023)

    Table 42. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 43. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2024-2029) & (K Units)

    Table 44. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Region (2024-2029)

    Table 45. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2024-2029) & (US$ Million)

    Table 46. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Region (2024-2029)

    Table 47. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

    Table 48. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

    Table 49. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) & (K Units)

    Table 50. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Application (2018-2023)

    Table 51. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) & (US$ Million)

    Table 52. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Application (2018-2023)

    Table 53. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2018-2023) & (USD/Unit)

    Table 54. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2024-2029) & (K Units)

    Table 55. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Application (2024-2029)

    Table 56. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2024-2029) & (US$ Million)

    Table 57. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Application (2024-2029)

    Table 58. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2024-2029) & (USD/Unit)

    Table 59. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) (K Units)

    Table 60. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) & (US$ Million)

    Table 61. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) (K Units)

    Table 62. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) & (US$ Million)

    Table 63. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) (K Units)

    Table 64. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) & (US$ Million)

    Table 65. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) (K Units)

    Table 66. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) & (US$ Million)

    Table 67. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) (K Units)

    Table 68. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2023) & (US$ Million)

    Table 69. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (K Units)

    Table 70. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2018-2023)

    Table 71. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (US$ Million)

    Table 72. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2018-2023)

    Table 73. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (K Units)

    Table 74. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2024-2029)

    Table 75. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (US$ Million)

    Table 76. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2024-2029)

    Table 77. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (K Units)

    Table 78. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2018-2023)

    Table 79. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (US$ Million)

    Table 80. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2018-2023)

    Table 81. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (K Units)

    Table 82. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2024-2029)

    Table 83. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (US$ Million)

    Table 84. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2024-2029)

    Table 85. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2018-2023) & (K Units)

    Table 86. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Region (2018-2023)

    Table 87. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2018-2023) & (US$ Million)

    Table 88. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Region (2018-2023)

    Table 89. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2024-2029) & (K Units)

    Table 90. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Region (2024-2029)

    Table 91. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2024-2029) & (US$ Million)

    Table 92. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Region (2024-2029)

    Table 93. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (K Units)

    Table 94. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2018-2023)

    Table 95. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (US$ Million)

    Table 96. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2018-2023)

    Table 97. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (K Units)

    Table 98. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2024-2029)

    Table 99. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (US$ Million)

    Table 100. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2024-2029)

    Table 101. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (K Units)

    Table 102. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2018-2023)

    Table 103. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2018-2023) & (US$ Million)

    Table 104. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2018-2023)

    Table 105. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (K Units)

    Table 106. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Country (2024-2029)

    Table 107. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2024-2029) & (US$ Million)

    Table 108. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Country (2024-2029)

    Table 109. Eli Lilly Company Information

    Table 110. Eli Lilly Introduction and Business Overview

    Table 111. Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 112. Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product

    Table 113. Eli Lilly Recent Development

    Table 114. Janssen Pharmaceuticals Company Information

    Table 115. Janssen Pharmaceuticals Introduction and Business Overview

    Table 116. Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 117. Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product

    Table 118. Janssen Pharmaceuticals Recent Development

    Table 119. Astellas Company Information

    Table 120. Astellas Introduction and Business Overview

    Table 121. Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 122. Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product

    Table 123. Astellas Recent Development

    Table 124. Boehringer Ingelheim Company Information

    Table 125. Boehringer Ingelheim Introduction and Business Overview

    Table 126. Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 127. Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product

    Table 128. Boehringer Ingelheim Recent Development

    Table 129. AstraZeneca Company Information

    Table 130. AstraZeneca Introduction and Business Overview

    Table 131. AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 132. AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product

    Table 133. AstraZeneca Recent Development

    Table 134. Bristol Myers Squibb Company Information

    Table 135. Bristol Myers Squibb Introduction and Business Overview

    Table 136. Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 137. Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product

    Table 138. Bristol Myers Squibb Recent Development

    Table 139. Kotobuki Pharmaceutical Company Information

    Table 140. Kotobuki Pharmaceutical Introduction and Business Overview

    Table 141. Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 142. Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product

    Table 143. Kotobuki Pharmaceutical Recent Development

    Table 144. Key Raw Materials Lists

    Table 145. Raw Materials Key Suppliers Lists

    Table 146. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trends

    Table 147. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers

    Table 148. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Challenges

    Table 149. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints

    Table 150. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List

    Table 151. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream Customers

    Table 152. Research Programs/Design for This Report

    Table 153. Key Data Information from Secondary Sources

    Table 154. Key Data Information from Primary Sources

List of Figures

    Figure 1. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture

    Figure 2. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 3. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Status and Outlook (2018-2029) & (US$ Million)

    Figure 4. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Status and Outlook (2018-2029) & (K Units)

    Figure 5. Product Picture of Invokana (Canagliflozin)

    Figure 6. Global Invokana (Canagliflozin) Sales YoY Growth (2018-2029) & (K Units)

    Figure 7. Product Picture of Jardiance (Empagliflozin)

    Figure 8. Global Jardiance (Empagliflozin) Sales YoY Growth (2018-2029) & (K Units)

    Figure 9. Product Picture of Farxiga/Forxiga (Dapagliflozin)

    Figure 10. Global Farxiga/Forxiga (Dapagliflozin) Sales YoY Growth (2018-2029) & (K Units)

    Figure 11. Product Picture of Suglat (Ipragliflozin)

    Figure 12. Global Suglat (Ipragliflozin) Sales YoY Growth (2018-2029) & (K Units)

    Figure 13. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2018-2029) & (US$ Million)

    Figure 14. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2022 & 2029

    Figure 15. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Type in 2022

    Figure 16. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Type in 2022

    Figure 17. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Type in 2022

    Figure 18. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Type in 2022

    Figure 19. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Type in 2022

    Figure 20. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Type in 2022

    Figure 21. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Type in 2022

    Figure 22. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Type in 2022

    Figure 23. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Type in 2022

    Figure 24. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Type in 2022

    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in 2022

    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2022

    Figure 27. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 28. Product Picture of Hospital

    Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)

    Figure 30. Product Picture of Medical Research Institute

    Figure 31. Global Medical Research Institute Sales YoY Growth (2018-2029) & (K Units)

    Figure 32. Product Picture of Other

    Figure 33. Global Other Sales YoY Growth (2018-2029) & (K Units)

    Figure 34. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2018-2029) & (US$ Million)

    Figure 35. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2022 & 2029

    Figure 36. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Application in 2022

    Figure 37. North America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Application in 2022

    Figure 38. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Application in 2022

    Figure 39. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Application in 2022

    Figure 40. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Application in 2022

    Figure 41. Asia-Pacific Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Application in 2022

    Figure 42. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Volume by Application in 2022

    Figure 43. Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Application in 2022

    Figure 44. Middle East and Africa Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Value by Application in 2022

    Figure 45. Key Raw Materials Price

    Figure 46. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Cost Structure

    Figure 47. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Industrial Chain Analysis

    Figure 48. Channels of Distribution

    Figure 49. Distributors Profiles

    Figure 50. Bottom-up and Top-down Approaches for This Report

    Figure 51. Data Triangulation

    Figure 52. Key Executives Interviewed